IV 

118TH CONGRESS 

1ST SESSION H. RES. 415 

Expressing support for the designation of May as ‘‘National Bladder Cancer 

Awareness Month’’. 

IN THE HOUSE OF REPRESENTATIVES 

MAY 17, 2023 

Mr. CARTWRIGHT (for himself, Mr. ADERHOLT, Ms. BARRAGA ́N, Ms. CLARKE

of New York, Mr. CLEAVER, Mr. CONNOLLY, Mr. DAVIS of North Carolina, Mr. FITZPATRICK, Mr. GRIJALVA, Mr. KRISHNAMOORTHI, Ms. NORTON, Mr. PAYNE, Ms. PORTER, Mr. RUIZ, Mr. DAVID SCOTT of Georgia, 

Ms. SEWELL, Mr. TONKO, Mrs. TRAHAN, and Ms. WILD) submitted the 

following resolution; which was referred to the Committee on Energy and 

Commerce 

RESOLUTION 

Expressing support for the designation of May as ‘‘National 

Bladder Cancer Awareness Month’’. 

Whereas increased public awareness and early treatment of 

bladder cancer will save thousands of lives; 

Whereas more than 800,000 families in the United States 

live with bladder cancer; 

Whereas it is estimated that more than 82,290 people in the 

United States, or over 230 Americans every day, will be 

diagnosed with bladder cancer in 2023, including over 

62,420 men and 19,870 women; 


pbinns on DSKJLVW7X2PROD with $$_JOB
2 

•HRES 415 IH 

Whereas it is estimated that bladder cancer will kill more 

than 16,710 Americans this year alone; 

Whereas the bladder cancer diagnosis rate is expected to increase by 1.35 percent in 2023, while many other forms 

of cancer are projected to decline; 

Whereas bladder cancer can directly impact all people, regardless of age, sex, and race; 

Whereas bladder cancer is among the top 7 most diagnosed 

cancers in the United States, and the top 4 most commonly diagnosed cancers for our honored veterans; 

Whereas, if diagnosed early, bladder cancer is highly treatable, but survivability rates decrease substantially with 

later detection; 

Whereas smoking and environmental or occupational exposure to carcinomic chemicals are the top causes of bladder cancer; 

Whereas studies have shown a higher level of bladder cancer 

in firefighters, veterans, and senior citizens than in the 

general public; 

Whereas bladder cancer symptoms, such as blood in the 

urine, are easily recognized, however, many Americans 

are unaware of the warning signs and often put off diagnostic testing and treatment; 

Whereas bladder cancer is known as one of the most expensive cancers to treat on a per patient basis and has a reoccurrence rate of approximately 50 to 80 percent, requiring lifelong surveillance; 

Whereas, while bladder cancer is more prevalent in men, 

women are commonly diagnosed at a later stage and face 


pbinns on DSKJLVW7X2PROD with $$_JOB
3 

•HRES 415 IH 

a worse prognosis even when diagnosed at the same stage 

as men; 

Whereas there have been limited significant breakthroughs in 

the past 30 years to advance the treatment of and move 

toward a cure for bladder cancer; 

Whereas the quality of life and chance of survival for a bladder cancer patient depends largely on new advancements 

and a renewed focus on research from both the Federal 

Government and private industry; 

Whereas increased awareness for bladder cancer will promote 

earlier diagnosis and increased chances of survival; 

Whereas, in 2023, Congress will require the Department of 

Veterans Affairs to dramatically increase bladder cancer 

treatments for the Nation’s veterans, living up to the 

promise the Nation made decades ago; 

Whereas based on the Nation’s experience diagnosing and 

caring for Vietnam veterans exposed to carcinogenic 

chemicals such as Agent Orange and Agent Blue, efforts 

are underway to document current servicemembers’ exposure to burn pits; 

Whereas the Congressionally Directed Medical Research Programs, working concurrently with the National Institutes 

of Health, annually fund the high-risk, high-reward, research required to one day discover a cure for bladder 

cancer; 

Whereas traditionally throughout May, survivors, caregivers, 

and loved ones unite for walks in communities across the 

United States to raise awareness for bladder cancer along 

with funds for bladder cancer research; 

Whereas the Bladder Cancer Advocacy Network has worked 

for more than 18 years to raise public awareness for 


pbinns on DSKJLVW7X2PROD with $$_JOB
4 

•HRES 415 IH 

bladder cancer while providing patients with the knowledge, resources, and support they need to navigate their 

personal bladder cancer journey; 

Whereas the Bladder Cancer Advocacy Network annually 

funds cutting edge research in search of better treatments and a final cure for bladder cancer while working 

every day to raise public awareness, support patients, and 

increase research; and 

Whereas May would be an appropriate month to designate as 

‘‘National Bladder Cancer Awareness Month’’: Now, 

therefore, be it 

1 Resolved, That the House of Representatives— 

2 (1) supports the designation of ‘‘National Blad3 der Cancer Awareness Month’’; 

4 (2) supports the goals and ideals of ‘‘National 

5 Bladder Cancer Awareness Month’’; and 

6 (3) calls on the people of the United States, in7 terested groups, the research community, and af8 fected persons to— 

9 (A) promote awareness of bladder cancer 

10 and foster understanding of the impact of the 

11 disease on patients, their families, caregivers, 

12 and their community; 

13 (B) take an active role in the fight to end 

14 bladder cancer; and 


pbinns on DSKJLVW7X2PROD with $$_JOB
5 

•HRES 415 IH 

1 (C) observe ‘‘National Bladder Cancer 

2 Awareness Month’’ with appropriate ceremonies 

3 and activities. 

Æ 


pbinns on DSKJLVW7X2PROD with $$_JOB